Introduction
Stimulation of postsynaptic metabotropic glutamate receptors portant for improving the integrity of synaptic transmission (mGluRs) activates non-specific cationic conductances (Crepel through neuronal circuits and promoting the induction of syet al., 1994; Zheng et al., 1994) and inhibits a number of dif-naptic plasticity, e.g., long-term potentiation (LTP) (McGuiferent potassium conductances including the slow calcium-ness et al., 1991). However, it has not yet been established dependent afterhyperpolarizing current (IAHP), the voltage-which of the eight mGluR subtypes, so-far identified, mediates dependent M current and a leak current (Charpak et al., 1990 ; these postsynaptic effects in CAl pyramidal neurones. Guerineau et al., 1994) . In hippocampal pyramidal neurones Combined pharmacological and biochemical studies have the consequences of these effects is postsynaptic depolariza-enabled classification of mGluRs into three groups. Group I tion, an overall increase in input resistance (Stratton et al., comprises mGluRs 1 and 5 which promote inositol-1,4,5-tri-1989; Charpak et al., 1990; Desai & Conn, 1991) and a loss of sphosphate (IP3) production. The remaining mGluR subtypes spike frequency adaptation (alternatively referred to as 'ac-inhibit adenosine 3':5'cyclic-monophosphate (cyclic AMP) The subtype specificity of a number of mGluR agonists and antagonists has now been determined by screening these compounds in biochemical assays on brain slices and nonneuronal cell lines transfected with cDNA for individual mGluR subtypes. In these latter experiments mGluRs 1, 2 and 4 have been used as representatives of groups I, II and III mGluRs, respectively. 2S,1'S,2'S-2-(2'-carboxycyclopropyl)-glycine (L-CCGl) is an agonist for group II mGluRs at concentrations < 1 yM but at higher concentrations also activates groups I and III mGluRs . The (1S,3R)-and (IS,3S)-isomers of 1-aminocyclopentane-1,3-dicarboxylic acid (ACPD) activate both groups I and II mGluRs but have little or no activity at group III mGluRs Nakanishi, 1992; Watkins & Collingridge, 1994) . In contrast, (S)-3,5-dihydroxyphenylglycine ((S)-DHPG), (2S,1'R,2'R,-3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV) and L-AP4 are selective agonists for group I, group II and group III mGluRs, respectively (Ito et al., 1992; Nakanishi, 1992; Hayashi et al., 1993) . The mGluR antagonists (+ )-a-methyl-4-carboxyphenylglycine ((+)-MCPG) and (S)-4-carboxyphenylglycine ((S)-4CPG) (Eaton et al., 1993; Jane et al., 1993) block group I mGluRs but (+)-MCPG is an antagonist and (S)-4CPG is an agonist at group II mGluRs (Cavanni et al., 1994; Hayashi et al., 1994; Thomsen et al., 1994) .
We have now tested systematically these agonists and antagonists in order to determine the pharmacology of the postsynaptic mGluRs that mediate depolarization, increase in input resistance and reduction in spike frequency adaptation in CAl pyramidal neurones.
A preliminary report of these findings has been published in abstract form .
Methods
Experiments were performed on hippocampal slices obtained from female Wistar rats (4-6 weeks old) as described previously (Davies et al., 1990) . In brief, animals were anaesthetized with halothane (3.5%) and subsequently decapitated. Coronal slices (400 Mm thick) containing hippocampus were cut with a Campden vibroslicer. The hippocampal region was dissected from these slices and area CA3 removed. The resultant CA3-ectomized hippocampal slices were stored at room temperature for at least 1 h before being transferred to an interface recording chamber maintained at 30-32°C. Slices rested on a nylon mesh at the interface of a warmed perfusing artificial cerebrospinal fluid containing (mM): NaCl 124, KCl 3, NaHCO3 26, CaCl2 2, MgSO4 1, D-glucose 10, NaH2PO4 1.25, bubbled with a 95% 02/5% C02 mixture. Intracellular recordings were obtained from neurones in stratum pyramidale using glass microelectrodes (40-90 MCI) filled with potassium methylsulphate (2 M) connected to an Axoclamp-2 amplifier used in switch-clamp mode (Axon Instruments, Foster City, CA, U.S.A.). To study spike frequency adaptation and input resistance pyramidal cells were activated directly by passing current pulses (amplitude ± 0.1 -0.5 nA, duration 500 -700 ms) through the intracellular recording electrode every 30 -60 s to depolarize or hyperpolarize the neurone, respectively. The effects of mGluR agonists on input resistance and spike frequency adaptation were studied at a fixed membrane potential by injecting d.c. current to compensate for any agonist-induced depolarization. Changes in spike frequency adaptation were quantified in terms of the number of action potentials fired during a depolarizing step in the presence of the mGluR agonist as a percentage of that in control medium. As such the increase in spike firing reflects a combination of the increased depolarization induced by the current step (due to the increase in the cell input resistance) and the reduction in spike frequency adaptation per se. Drugs were administered by addition to the superfusing medium and were applied for a sufficient period to allow their full equilibration. Experiments were performed either in control medium or in medium containing 20 yM and 50 MM D-2-amino-5-phosphonopentanoate (D-AP5) to block any possible activation of ionotropic excitatory amino acid receptors by the mGluR agonists or antagonists . Each drug was dissolved in distilled water or equimolar NaOH at 100-1000 times its final bath applied concentration.
Statistical analysis
Results were analysed with either Student's t tests or analysis of variance (ANOVA) with P <0.05 being taken as indicating statistical significance. n signifies the number of times a result was obtained, which is the same as the number of slices tested (each slice was obtained from a separate rat).
Results
The present data were collected from 66 neurones with resting membrane potentials more negative than -55 mV, action potential amplitudes of > 85 mV and resting input resistances in the range 30-50 MQ.
Effects of mGluR agonists
In the first series of experiments the potency of the broad spectrum mGluR agonists (lS,3R)-ACPD, (1S,3S)-ACPD and L-CCG1 was assessed. In 11 neurones (IS,3R)-ACPD, at a concentration of 50 gM, caused a depolarization of 5 ± 2 mV, an increase in input resistance of 19 + 4% and a reduction in spike frequency adaptation (quantified in terms of the increase in action potential firing during a 500 ms depolarizing step) of 243 ± 52%. With 100 gM (1S,3R)-ACPD all these effects were more pronounced (n= 10); i.e. (lS,3R)-ACPD caused a depolarization of 10±3 mV, an increase in input resistance of 29 + 7% and an increase in depolarization-induced action potential firing of 323 ± 63%. There was considerable intercell variability in the effects of a fixed concentration of (1S,3R)-ACPD; for example, in three of the eleven neurones tested, 50 gM (lS,3R)-ACPD caused little or no depolarization whereas in others it caused a depolarization up to 12 mV, a value similar to the mean depolarization induced by 100 ,M. However, for each agonist application, a maximum effect was obtained after a 5 -10 min perfusion and persisted at a constant level for the time (up to 1 h) which the agonist was present. To assess whether each neurone was sensitive to each agonist we tested individual agonists in turn on the same neurone. In these experiments all three agonists, when applied at 100 gM, increased the excitability of the neurone under investigation (Figure 1 ; n = 10).
We tested next the effectiveness of group selective mGluR agonists. The racemic mixture ((SR)-; 50-100 gM) and the resolved (S)-isomer (20-50 gM) of the group I-selective agonist, DHPG, caused a depolarization of 4-15 mV, an increase in input resistance of 20-35% and an increase in depolarization-induced action potential firing of 220-433% (n=15; Figure 2a ). The apparently higher potency of (S)-DHPG over (1S,3R)-ACPD was borne out in experiments in which both agonists were applied to the same neurone. Thus, in three 9±2mV and 25±5% for (lS,3R)-ACPD, 7±1mV and 23±2% for (lS,3S)-ACPD, and 7±2mV and 21±4% for L-CCGl, respectively (n = 10). (The initial depolarization of the neurone in (a) without a noticeable increase in cell input resistance was a consistent finding in this study (see also Figure 3 ) and may reflect the dual action of mGluR agonists in inhibiting potassium conductances and activating non-specific cationic conductances and 100 gM (1S,3R)-ACPD were 9 ± 2 mV and 8 ± 2 mV, respectively (not illustrated). In contrast, the respective group II and group III selective agonists DCG-IV (100 pM; n = 3) and L-AP4 (500-1000 pM; n=5, P>0.05) invariably had no postsynaptic effects (Figures 2b and c) .
One problem with experiments in brain slices when applying agonists which increase neuronal excitability is that the effects monitored in the neurone under study may reflect indirect actions through activation of complex neuronal circuits and the release ofother neurotransmitters. To address this possiblity we repeated the applications of the effective mGluR agonists in the presence of 200 /IM (± )-baclofen to block both excitatory and inhibitory synaptic transmission (Thompson et al., 1992) and the release of other neurotransmitters which could have similar excitatory actions (e.g., catecholamines; Bowery, 1993 (a) ). In the presence of (lS,3R)-ACPD the larger upward deflections represent the firing of action potentials. The absolute amplitude of these events is truncated due to the slow response time of the chart recorder. The arrow marks the point where d.c. current injection was applied to restore the membrane potential of the cell to that prior to ( +)-baclofen application. (c) Shows, on an expanded time scale, examples of the input resistance of the cell at the times indicated by the numbers 1-4. Note that (IS,3R)-ACPD induces spontaneous e.p.s.p.s in control medium (c2) but not in the presence of (±)-baclofen (c4). Each trace is an average of four consecutive responses. (d) Shows examples of responses to depolarizing current steps (+0.15nA) recorded at the times indicated by 1-4. The initial membrane potential of the cell was -62mV. Note that in (a-d) although (± )-baclofen abolished all synaptic transmission it did not inhibit the effects of (1S,3R)-ACPD. Thus, in three neurones the mean depolarizations, increases in input resistance and depolarizatio-induced action potential firing induced by (lS,3R)-ACPD in the absence and presence of (±)-baclofen (200 gM) were 11 ± 3 mV and 10 ± 2 mV, 33 ± 4% and 32 ± 6%, and 367 ± 63% and 345 ± 73%, long.) For (e) and (f) the magnitude of the depolarizations induced by (1S,3S)-ACPD and L-CCG1 in the absence and presence of (+ )-MCPG were 9 ± 3 mV and 2 ± 1 mV, and 7 ± 2 mV and 2 ± 1 mV, respectively. * and t represent statistical significance at the P<0.05 level for mGluR agonist treated versus control, and for mGluR agonist plus (+)-MCPG-treated versus mGluR agonisttreated neurones, respectively. Postsynaptc metabotropic glutamate receptors increase in input resistance and increase in depolarization-induced action potential firing induced by 50-100 gM (lS,3R)-ACPD (n = 7; Figure 4a -c). These effects were stereoselective as (-)-a-methyl-4-carboxyphenylglycine had no effect (n = 2; not illustrated). (+)-MCPG (1000 yM) was less effective at reversing the effects of 500 gM (1S,3R)-ACPD (n = 5; Figure 4d) ; an observation consistent with the competitive nature of its block (Eaton et al., 1993) . ( 11 ±3 mV and 3±2 mV, 29±8% and 13±6%, and 306 ± 71% and 144 ± 27%, respectively (n = 3). (S)-4CPG (1000 pM) was also effective in reversing the excitatory effects induced by (lS,3R)-ACPD (50-100 pM; n = 3), (lS,3S)-ACPD (50-100 uM; n = 3) and L-CCG1 (100 pM; n = 2) ( Figure 5 ).
Selectivity of mGluR antagonist action
To ensure that (+ )-MCPG and (S)-4CPG were acting at the level of the receptor itself, rather than down-stream of receptor activation, we tested these antagonists against reduction of spike frequency adaptation induced by activation of muscarinic acetylcholine receptors and noradrenoceptors ( Nicoll, 1983; Madison & Nicoll, 1982) . Neither (+)-MCPG (1000 pM) nor (S)-4CPG (1000 pM) affected the increase in depolarization-induced action potential firing produced by either carbachol (1 pM; n=3 and n=2, respectively) or noradrenaline (10 yM; n = 4 and n = 2, respectively; Figure 6 ). In contrast, the effects of these agonists were reversed by atropine (I0 pM; n = 3) and propranolol (100 1M; n = 4), respectively.
Discussion
Agonist pharmacology
The present study confirms that (1S,3R)-ACPD and (lS,3S)-ACPD reduce spike frequency adaptation and cause postsynaptic depolarization with an associated increase in input resistance in CAl pyramidal neurones (Desai et al., 1992) .
These effects appear to be due to a direct activation of mGluRs, in CAl pyramidal neurones, because they persist in the presence of ( ± )-baclofen which inhibits the release of most neurotransmitters and hyperpolarizes neurones to membrane potentials far beyond the threshold for firing action potentials.
We have demonstrated also that L-CCG1 and (S)-DHPG mediate similar effects to ACPD. In contrast, L-AP4 and DCG-IV per se are ineffective at postsynaptic mGluRs in these neurones. That L-AP4 has no effect on naive preparations is consistent with a report by Harris et al. (1987) who demonstrated that L-AP4 depolarized CAI pyramidal neurones only after the slice had previously been exposed to quisqualate, i.e. following so-called 'priming'. Although quisqualate was not used in the present study it has been reported that ACPD is also able to 'prime' certain effects of L-AP4 (Whittemore & Cotman, 1991) ; however, this phenomenon was not observed in the present study. The agonist pharmacology of the mGluR(s) responsible for the excitatory effects in CAl pyramidal neurones that were analysed in the present study is similar to that of the mGluRs that mediate depolarization of spinal cord motoneurones (Eaton et al., 1993; Ishida et al., 1993) . In both sets of neurones the effectiveness of the agonists tested correlates well with their capacity to generate the production of IP3 in brain slices (Ito et al., 1992; Cartmell et al., 1993; Schoepp, 1993; Schoepp et al., 1994) and to activate mGluRl, rather than mGluR2 or 4, transfected cells (Nakagawa et al., 1990; Ito et al., 1992; Nakanishi, 1992; Kristensen et al., 1993; Tanabe et al., 1993) . In keeping with this, the initial studies characterizing the effects of the postsynaptic mGluR on CAl pyramidal neurones were performed with quisqualate (Stratton et al., 1989; Charpak et al., 1990) which strongly promotes the production of IP3 in brain slices (Palmer et al., 1989; Abe et al., 1992; Schoepp, 1993) and mGluRl transfected cells but only weakly inhibits cyclic AMP formation in brain slices (Genazzani et al., 1993) and mGluR2 or mGluR4 transfected cells (Nakanishi, 1992; Tanabe et al., 1992) .
Antagonist pharmacology
As regards antagonist pharmacology, we have demonstrated that 1000 gM (+ )-MCPG reverses the effects of 50-100 pM (1S,3R)-ACPD. These data are consistent with our initial observations that 500-1000 pM of the racemic mixture of MCPG ((± )-MCPG) inhibits the reduction in spike frequency adaptation induced by 30-50 jM (1S,3R)-ACPD (Bashir et al., 1993) . A recent report by Manzoni et al. (1994) Noradrenaline 10 gM these findings; however, Chinestra et al., (1993) suggest that (±)-MCPG is not an antagonist at mGluRs in the hippocampal CAI region. Possible factors that might explain this discrepancy are (i) the weak spike frequency adaptation observed by the latter authors under control conditions and (ii) their inability to demonstrate that (±)-MCPG was active in any of their test systems. We have now extended our study to show that (+ )-MCPG reverses the depolarization, increase in input resistance and reduction in spike frequency adaptation induced by mGluR agonists, independently of the mGluR agonist used to induce these effects, and that, as in the spinal cord and the thalamus , it is the (+)-isomer of MCPG that is the active enantiomer. However, (+ )-MCPG is a weak competitive antagonist Watkins & Collingridge, 1994) . It is therefore important to consider carefully the agonist and antagonist concentrations when examining its effects. A further advance towards characterizing the mGluR subtype in CAl pyramidal neurones is the observation that (S)-4CPG is also an antagonist of the mGluR that mediates changes in the passive membrane properties and spike frequency adaptation in these neurones. Like (+)-MCPG this compound is also a relatively weak antagonist of mGluRs (Watkins & Collingridge, 1994) and therefore was used at 1000 M4M. This profile of antagonism of mGluRs in CAl pyramidal neurones is similar to that of mGluRs which depolarize spinal cord motoneurones Eaton et al., 1993) and CA3 pyramidal neurones (Gerber et al., 1993; Guerineau et al., 1994) . In the nucleus tractus solitarius (NTS), however, neither 250 gM (±)-MCPG nor 500 gM (SR)-4CPG reversed significantly an inward current induced by 25 gM (lS,3R)-ACPD (Glaum et al., 1993 ). This does not, however, necessarily indicate that different classes of mGluR mediate these similar excitatory effects in different regions of the CNS and could be explained by the low potency of (+ )-MCPG and (SR)-4CPG at inhibiting these excitatory effects of ACPD. The pharmacology of postsynaptic mGluRs on hippocampal CAl pyramidal neurones does differ, however, from presynaptic mGluRs on glutamate terminals in the CAl region and spinal cord (Baskys & Malenka, 1991; Pook et al., 1993; Vignes et al., 1995) .
The antagonist pharmacology strongly implicates group I mGluRs in the mediation of the postsynaptic excitation of hippocampal CAl pyramidal neurones since both (+ )-MCPG and (S)-4CPG are antagonists at mGluR1 while (+ )-MCPG is an antagonist at mGluR2 and (S)-4CPG is an agonist at these receptors. Both antagonists are inactive at mGluR4 (Hayashi et al., 1994; Thomsen et al., 1994) . Consistent with this categorization, (+ )-MCPG and (S)-4CPG are antagonists of (lS,3R)-ACPD-stimulated IP3 production in brain slices (Watkins & Collingridge, 1994) .
However, a comparison of these results with those generated previously with L-2-amino-3-phosphonopropionate (L-AP3) is complicated by the disparities that exist as to the capacity of this compound to antagonise either IP3 production, or electrophysiological effects, in brain slices and cells transfected with group I mGluRs (Aramori & Nakanishi, 1991; Abe et al., 1992; Desai et al., 1992; Hu & Storm, 1992; Schoepp, 1993; Saugstad et al., 1995) .
Which subtype of mGtuR excites CAI pyramidal neurones?
Although the profiles of agonist and antagonist pharmacology indicate group I mGluRs as the mediators of postsynatpic depolarization, increase in input resistance and inhibition of spike frequency adaptation in CAl pyramidal neurones, the identity of the actual mGluR(s) is not defined. In situ hybridisation and immunohistochemical studies have demonstrated expression of both mGluR5 and mGluRl (Abe et al., 1992; Shigemoto et al., 1993; Fotuhi et al., 1994) in CAl neurones. In mice in which the mGluRl gene has been functionally deleted (1S,3R)-ACPD produces postsynaptic excitatory effects indistinguishable from controls (Aiba et al., 1994; Conquet et al., 1994) . This shows that receptors other than mGluRl can mediate these effects (but does not necessarily preclude a role of mGluRl in normal animals). The simplest interpretation of these data, however, is that mGluR5 mediates these excitatory effects in CAl pyramidal neurones.
